The Lancet | July 2021 “Clinical trials need to be decarbonised and we propose a strategy for doing so.”
Resource Category Archives
Decarbonising Clinical Trials at Novartis
Novartis has embedded environmental sustainability across the clinical trial lifecycle, from protocol design through to close-out. This case study explains the overall approach and provides details around three targeted initiatives (investigational medication distribution, reusable shipping boxes, and clinical sample management) which are delivering significant operational, environmental, and financial benefits.
